Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia (Q45230545)

From Wikidata
Jump to navigation Jump to search
scientific article published in January 2005
edit
Language Label Description Also known as
English
Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia
scientific article published in January 2005

    Statements

    Polymorphisms in FcgammaRIIIA (CD16) receptor expression are associated with clinical response to rituximab in Waldenström's macroglobulinemia (English)
    Steven P Treon
    Mark Hansen
    Andrew R Branagan
    Sigitas Verselis
    Christos Emmanouilides
    Eva Kimby
    Stanley R Frankel
    Nikolaos Touroutoglou
    Barry Turnbull
    Edward A Fox
    1 January 2005
    474-481

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit